Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Head and Neck Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 5 Oropharyngeal Neoplasms 3 Tongue Neoplasms 1 Thyroid Neoplasms 1 Radiation Injuries 1 Pain, Postoperative 1 Pain 1 Mucositis 1 Mouth Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma 1

Interventions

Cisplatin 76 Radiotherapy 44 pembrolizumab 39 Cetuximab 38 Paclitaxel 34 Carboplatin 33 Docetaxel 30 Fluorouracil 25 Radiotherapy, Intensity-Modulated 22 Nivolumab 18 Drug Therapy 14 Radiation 12 Erlotinib Hydrochloride 9 cemiplimab 8 Magnetic Resonance Spectroscopy 8 130-nm albumin-bound paclitaxel 8 durvalumab 7 atezolizumab 7 Cyclophosphamide 7 Afatinib 7 Surgical Procedures, Operative 6 Panitumumab 6 Leucovorin 6 Chemoradiotherapy 6 fludarabine 5 aldesleukin 5 Radiosurgery 5 Oxaliplatin 5 Methotrexate 5 Gemcitabine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma, Squamous Cell × Neck Dissection × Clear all

NCT02269020 2019-01-11

RoboCurage ORL

Centre Hospitalier Universitaire de Nīmes

Phase 1 Completed

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡